ValueAct Holdings, L.P. Insider Trading $BVF Bausch Health Companies Inc.
Get free email notifications about insider trading for ValueAct Holdings, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ValueAct Holdings, L.P.. ValueAct Holdings, L.P. is 10% Owner in ACXIOM CORP ($ACXM) and Director in ADOBE SYSTEMS INC ($ADBE) and Director in ARMSTRONG WORLD INDUSTRIES INC ($AWI) and 10% Owner in GARTNER INC ($IT) and Director in GARTNER INC ($IT) and Director in HAWAIIAN ELECTRIC INDUSTRIES INC ($HE) and 10% Owner in VALEANT PHARMACEUTICALS INTERNATIONAL ($ICN) and 10% Owner in IMMUCOR INC ($BLUD) and 10% Owner in Hillshire Brands Co ($HSH) and 10% Owner in Motorola Solutions, Inc. ($MOT) and 10% Owner in OMNICARE INC ($NYSE: OCR) and 10% Owner in TRINITY INDUSTRIES INC ($NYSE/TRN) and Director in UNIFI INC ($UFI) and Director in Valeant Pharmaceuticals International, Inc. ($BVF) and 10% Owner in GEVITY HR INC ($GVHR) and 10% Owner in ALLIANCE DATA SYSTEMS CORP ($ADS) and Director in ALLIANCE DATA SYSTEMS CORP ($ADS) and Director in CBRE GROUP, INC. ($CBG) and Director in Seagate Technology plc ($STX) and 10% Owner in WILLIS TOWERS WATSON PLC ($WSH) and in ABBOTT MEDICAL OPTICS INC ($AVO) and 10% Owner in ABBOTT MEDICAL OPTICS INC ($AVO) and 10% Owner in SIRVA INC ($SIR) and 10% Owner in PRA International ($PRAI) and Director in Allison Transmission Holdings Inc ($ALSN) and 10% Owner in CHIMERA INVESTMENT CORP ($CIM) and 10% Owner in KKR & Co. L.P. ($KKR) and Director in MSCI Inc. ($MSCI) and 10% Owner in KAR Auction Services, Inc. ($KAR) and Director in KAR Auction Services, Inc. ($KAR) and Director in Armstrong Flooring, Inc. ($AFI) and in Arcosa, Inc. ($NYSE/ACA) and 10% Owner in Arcosa, Inc. ($NYSE/ACA).
ValueAct Holdings, L.P. in Bausch Health Companies Inc.
Trading Symbol: BVFIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ValueAct Holdings, L.P.: Director
Holdings: 0 shares
Latest Transaction: Jun 09 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ValueAct Holdings, L.P. in Bausch Health Companies Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVO, ADBE, ADS, ALSN, NYSE/ACA, AFI, AWI, BVF, CBG, CIM, IT, GVHR, HE, HSH, BLUD, KAR, KKR, ACXM, MOT, MSCI, NYSE: OCR, PRAI, STX, SIR, NYSE/TRN, UFI, ICN, WSH
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 09 2020 | BVF | Bausch Health Comp ... | ValueAct Holdings, L.P. | Director | Buy | P | 19.24 | 948,353 | 18,246,312 | 17,931,594 | 17 M to 17.9 M (+5.58 %) |
Jun 09 2020 | BVF | Bausch Health Comp ... | ValueAct Holdings, L.P. | Director | Sell | S | 19.24 | 948,353 | 18,246,312 | 0 | 948.4 K to 0 (-100.00 %) |
Jun 14 2019 | BVF | Bausch Health Comp ... | ValueAct Holdings, L.P. | Director | Sell | J | 0.00 | 111,440 | 0 | 948,353 | 1.1 M to 948.4 K (-10.52 %) |
Mar 16 2017 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 10.81 | 2,500,000 | 27,025,000 | 16,937,431 | 14.4 M to 16.9 M (+17.32 %) |
Mar 16 2017 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 10.88 | 500,000 | 5,440,000 | 14,437,431 | 13.9 M to 14.4 M (+3.59 %) |
Jun 07 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 48.78 | 2,807 | 136,925 | 17,559,302 | 17.6 M to 17.6 M (+0.02 %) |
Jun 07 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 48.20 | 50,000 | 2,410,000 | 17,556,495 | 17.5 M to 17.6 M (+0.29 %) |
Jun 07 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 47.55 | 100,000 | 4,755,000 | 17,506,495 | 17.4 M to 17.5 M (+0.57 %) |
Jun 06 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Grant | A | 0.00 | 8,062 | 0 | 81,106 | 73 K to 81.1 K (+11.04 %) |
Jun 04 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 46.46 | 100,000 | 4,646,000 | 17,406,495 | 17.3 M to 17.4 M (+0.58 %) |
Jun 04 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 46.90 | 100,000 | 4,690,000 | 17,306,495 | 17.2 M to 17.3 M (+0.58 %) |
Jun 04 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 47.92 | 50,000 | 2,396,000 | 17,206,495 | 17.2 M to 17.2 M (+0.29 %) |
May 30 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 47.85 | 97,193 | 4,650,685 | 17,156,495 | 17.1 M to 17.2 M (+0.57 %) |
May 30 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 48.34 | 50,000 | 2,417,000 | 17,059,302 | 17 M to 17.1 M (+0.29 %) |
May 30 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 48.57 | 50,000 | 2,428,500 | 17,009,302 | 17 M to 17 M (+0.29 %) |
May 24 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 47.70 | 100,000 | 4,770,000 | 16,959,302 | 16.9 M to 17 M (+0.59 %) |
May 24 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 46.29 | 100,000 | 4,629,000 | 16,859,302 | 16.8 M to 16.9 M (+0.60 %) |
May 24 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 47.54 | 100,000 | 4,754,000 | 16,759,302 | 16.7 M to 16.8 M (+0.60 %) |
May 21 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 47.16 | 100,000 | 4,716,000 | 16,659,302 | 16.6 M to 16.7 M (+0.60 %) |
May 21 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 47.54 | 125,000 | 5,942,500 | 16,559,302 | 16.4 M to 16.6 M (+0.76 %) |
May 21 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 47.90 | 125,000 | 5,987,500 | 16,434,302 | 16.3 M to 16.4 M (+0.77 %) |
May 21 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 48.62 | 100,000 | 4,862,000 | 16,309,302 | 16.2 M to 16.3 M (+0.62 %) |
May 21 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 48.62 | 200,000 | 9,724,000 | 16,209,302 | 16 M to 16.2 M (+1.25 %) |
May 21 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 48.75 | 200,000 | 9,750,000 | 16,009,302 | 15.8 M to 16 M (+1.27 %) |
May 16 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 50.98 | 295,000 | 15,039,100 | 15,809,302 | 15.5 M to 15.8 M (+1.90 %) |
May 10 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 51.00 | 369,000 | 18,819,000 | 15,514,302 | 15.1 M to 15.5 M (+2.44 %) |
May 10 2012 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Buy | P | 51.00 | 50,000 | 2,550,000 | 15,145,302 | 15.1 M to 15.1 M (+0.33 %) |
May 23 2011 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Grant | A | 0.00 | 4,397 | 0 | 73,044 | 68.6 K to 73 K (+6.41 %) |
May 17 2011 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Sell | S | 49.99 | 4,498,180 | 224,864,018 | 15,095,302 | 19.6 M to 15.1 M (-22.96 %) |
Mar 14 2011 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Sell | S | 37.30 | 7,366,419 | 274,767,429 | 19,593,482 | 27 M to 19.6 M (-27.32 %) |
Mar 08 2011 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Option Exercise | A | 0.00 | 1,319 | 0 | 1,319 | |
Dec 27 2010 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Option Exercise | A | 0.00 | 728 | 0 | 22,430 | |
Dec 27 2010 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Option Exercise | A | 0.00 | 723 | 0 | 22,285 | |
Dec 27 2010 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Option Exercise | A | 0.00 | 614 | 0 | 18,928 | |
Sep 30 2010 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Grant | A | 0.00 | 26,959,901 | 0 | 26,959,901 | 0 to 27 M |
Sep 30 2010 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Grant | A | 0.00 | 4,767 | 0 | 4,767 | 0 to 4.8 K |
Sep 30 2010 | BVF | Valeant Pharmaceut ... | ValueAct Holdings, L.P. | Director | Grant | A | 0.00 | 61,578 | 0 | 61,578 | 0 to 61.6 K |
Page: 1